MeiraGTx (NASDAQ:MGTX) Posts Quarterly Earnings Results, Misses Expectations By $0.14 EPS

Posted by Stanley Muller on May 14th, 2026

MeiraGTx (NASDAQ:MGTX – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.43) by ($0.14), FiscalAI reports. MeiraGTx had a negative return on equity of 1,065.47% and a negative net margin of 140.31%.The company had revenue of $0.29 million for the quarter, compared to the consensus estimate of $17.00 million.

MeiraGTx Stock Down 0.6%

NASDAQ:MGTX traded down $0.06 on Thursday, hitting $9.91. The stock had a trading volume of 514,302 shares, compared to its average volume of 594,691. The company has a market cap of $917.78 million, a PE ratio of -6.99 and a beta of 1.23. MeiraGTx has a 52 week low of $4.58 and a 52 week high of $11.85. The business’s fifty day moving average is $8.78 and its 200 day moving average is $8.27.

Analyst Ratings Changes

MGTX has been the topic of a number of recent analyst reports. Piper Sandler boosted their price target on shares of MeiraGTx from $26.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 22nd. Bank of America lifted their target price on MeiraGTx from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Friday, March 27th. Wall Street Zen upgraded MeiraGTx from a “sell” rating to a “hold” rating in a report on Sunday, April 5th. Zacks Research raised shares of MeiraGTx from a “strong sell” rating to a “hold” rating in a research report on Monday, March 9th. Finally, Chardan Capital reiterated a “buy” rating and issued a $35.00 price objective on shares of MeiraGTx in a research note on Friday, March 27th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $25.67.

Get Our Latest Stock Report on MeiraGTx

Insider Buying and Selling

In other MeiraGTx news, insider Stuart Naylor sold 27,661 shares of the firm’s stock in a transaction on Tuesday, April 7th. The shares were sold at an average price of $9.36, for a total value of $258,906.96. Following the transaction, the insider directly owned 668,505 shares of the company’s stock, valued at approximately $6,257,206.80. This trade represents a 3.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Alexandria Forbes sold 62,000 shares of the company’s stock in a transaction dated Tuesday, March 24th. The stock was sold at an average price of $7.41, for a total transaction of $459,420.00. Following the completion of the sale, the chief executive officer owned 1,449,695 shares in the company, valued at $10,742,239.95. This represents a 4.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 145,661 shares of company stock worth $1,290,647 in the last ninety days. Corporate insiders own 7.50% of the company’s stock.

Institutional Investors Weigh In On MeiraGTx

Institutional investors and hedge funds have recently bought and sold shares of the stock. BNP Paribas Financial Markets boosted its holdings in MeiraGTx by 43.8% during the 2nd quarter. BNP Paribas Financial Markets now owns 4,810 shares of the company’s stock worth $31,000 after acquiring an additional 1,466 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of MeiraGTx by 390.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 8,797 shares of the company’s stock worth $57,000 after buying an additional 7,005 shares during the last quarter. Abel Hall LLC purchased a new stake in shares of MeiraGTx during the fourth quarter valued at approximately $98,000. Hsbc Holdings PLC lifted its holdings in MeiraGTx by 24.3% during the fourth quarter. Hsbc Holdings PLC now owns 23,792 shares of the company’s stock worth $189,000 after acquiring an additional 4,649 shares during the period. Finally, Engineers Gate Manager LP purchased a new position in MeiraGTx in the fourth quarter worth $213,000. 67.48% of the stock is owned by hedge funds and other institutional investors.

MeiraGTx Company Profile

(Get Free Report)

MeiraGTx Holdings plc is a clinical-stage biotechnology company dedicated to developing gene therapies for the treatment of rare diseases. Founded in 2014 as an outgrowth of research at University College London, the company focuses on leveraging adeno-associated virus (AAV) vectors to deliver functional genes to target tissues. MeiraGTx’s pipeline spans ocular, central nervous system and systemic indications, addressing conditions such as inherited retinal dystrophies and neurodegenerative disorders that currently lack effective therapies.

The company’s lead programs include AAV-based candidates designed to restore or replace defective genes underlying rare retinal diseases and to modulate cellular pathways in neurological disorders.